Richard Baker Harrison Limited
Registered name: RICHARD BAKER HARRISON LIMITED
Part of Obg Pharmaceuticals Ltd groupRichard Baker Harrison Limited made £15.9m revenue and £940k profit in the year to 31 Dec 2025. read from filing text
Richard Baker Harrison Limited’s revenue fell 1% to £15.9m in the year to 31 Dec 2025, with £940k profit and 22 employees. The company is classified under “non-specialised wholesale trade” and is based in Liverpool; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Liverpool, North West
- Age
- 100 yrs · since 1926
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The immediate parent company is OBG Company Limited (previously OBG Pharmaceuticals Limited), a company incorporated in England and Wales.”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | £15m | £15.1m | £16.1m | £15.9m |
| Cost of sales | £11.9m | £11.3m | £12.3m | £11.9m |
| Gross profit | £3m | £3.7m | £3.8m | £4m |
| Operating profit | £933k | £775k | £1.4m | £1.4m |
| Profit before tax | £866k | £547k | £978k | £949k |
| Profit after tax | £865k | £536k | £978k | £940k |
| Profit (best available) | £865k | £536k | £978k | £940k |
| Staff costs | £1.2m | £1.9m | £1.4m | £1.4m |
| Employees (average) | 16 | 21 | 19 | 22 |
| Ratios | ||||
| Profit margin | 5.8% | 3.6% | 6.1% | 5.9% |
| Gross margin | 20.3% | 24.8% | 23.6% | 25.1% |
| Revenue per employee | £935k | £717k | £847k | £721k |
| Profit per employee | £54.1k | £25.5k | £51.5k | £42.7k |
| Growth (year on year) | ||||
| Revenue growth | — | ▲0.7% | ▲6.8% | ▼1.4% |
| Profit growth | — | ▼38% | ▲82.5% | ▼3.9% |
| Headcount growth | — | ▲31.3% | ▼9.5% | ▲15.8% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £3.1k | £11k | £19.2k | £73.9k |
| Net assets | £5.7m | £5.9m | £6.9m | £7.9m |
| Fixed assets | £6.1m | £6.3m | £6.2m | £6m |
| Current assets | £6.9m | £6.7m | £7.4m | £7.1m |
| Debtors | £2.6m | £2.7m | £2.6m | £2.4m |
| Deferred income | £207k | £1.4m | £1.7m | £668k |
| Source | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Sep 2026 |
How the business works
- Profit margin
- 5.9%
- Profit ÷ revenue.
- Gross margin
- 25.1%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £721k
- Revenue ÷ average employees.
- Profit per employee
- £42.7k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 37.8%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 4.2%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 15.2%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲14%
- Now £7.9m
- Cash at bank
- ▲285%
- Now £73.9k
- Headcount
- ▲16%
- Now 22
- Deferred income
- ▼62%
- Now £668k
- Fixed assets
- ▼3%
- Now £6m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Obg Pharmaceuticals Ltd (registered outside the UK register)ultimate parent75–100%
- Richard Baker Harrison Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (8)
- Baker Sillavan LimitedFigures not disclosed
- Dunwood Polymer Services LtdFigures not disclosed
- Dunwood Specialities LimitedFigures not disclosed
- Geniechem Europe LimitedFigures not disclosed
- Geniechem LimitedFigures not disclosed
- RBH Minerals UK LimitedFigures not disclosed
- Whitfield and Son LimitedFigures not disclosed
- Whitfield International LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Lows of Dundee LimitedDundee · Non-specialised wholesale trade
- Revenue
- £15.9m
- Profit
- £316k
- Staff
- 24
- Hydrachem LimitedLondon · Non-specialised wholesale trade
- Revenue
- £15.8m
- Profit
- £1.4m
- Staff
- 80
- DPS Tableware LimitedStone · Non-specialised wholesale trade
- Revenue
- £15.7m
- Profit
- £572k
- Staff
- 32
- Grafton International LimitedTamworth · Non-specialised wholesale trade
- Revenue
- £16m
- Profit
- £211k
- Staff
- 62
- JRP Distribution LimitedChichester · Non-specialised wholesale trade
- Revenue
- £16m
- Profit
- £703k
- Staff
- 36
- Rutland Trading Co LimitedChesterfield · Non-specialised wholesale trade
- Revenue
- £16.1m
- Profit
- £1.8m
- Staff
- 32
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £940k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Updated from Companies House on 11 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.